Stately Bio: $12 Million Closed For Developing Regenerative Medicines With Cellular Imaging Platform
Stately Bio, a company developing cell therapies using an ML-based live-cell imaging platform, announced $12 million in seed funding led by AIX Ventures, with participation from Dimension Capital, ...
A scientific review shows how integrating super-resolution imaging and single-cell omics establishes a dynamic, spatially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results